CRABP2 and arthritic joint disease: The increase was observed 7 to 18 days after injection in the K/BxN serum transfer model, a time span including the peak of inflammation at 9 days and the phase of resolution, which could indicate a role of Crabp2 in the auto-limitation of arthritis.